Corporate Banner
Satellite Banner
Molecular & Clinical Diagnostics
Scientific Community
Become a Member | Sign in
Home>News>This Article

Corgenix Expands Contract Services Business Unit

Published: Friday, May 03, 2013
Last Updated: Friday, May 03, 2013
Bookmark and Share
New dedicated website launched — highlights contract service capabilities, companion diagnostics.

Corgenix Medical Corporation announced the expansion of its Contract Services business and the launch of its dedicated Contract Services website, The new site complements the existing site and reflects the company’s strong growth and dedicated strategic approach to its Contract Services business unit for diagnostic products.

“Contract Services, including contract manufacturing, contract development, companion diagnostics and partner support activities, has become an increasingly important part of our business, and as a result we are significantly expanding our capabilities,” said Corgenix President and Chief Executive Officer Douglass Simpson. “Our company is already an established industry leader for in vitro diagnostics development and manufacturing. As the demand for companion diagnostics grows, Corgenix is adding new resources to assist pharmaceutical and biotechnology companies with the development of these promising tests, which aid in stratifying patient populations and determining the effectiveness of specific corresponding therapies.”

The company’s Contract Services business is supported by a dedicated team of highly qualified and experienced scientific researchers, laboratory and operations professionals. Corgenix’ facilities function as a full-service operation to support and partner with its customers on everything from product concept to product distribution.

In addition to contract manufacturing services, the company’s portfolio of outsourced services includes:

•    Product development
•    Technology application
•    Private labeling
•    Regulatory management
•    Warehousing and fulfillment
•    Distribution and commercialization

For more than twenty years, Corgenix has provided Contract Services to large and small medical companies, pharmaceutical and biotechnology companies, universities, research institutions and government agencies. The company’s expertise, quality system, solid infrastructure and state-of-the-art manufacturing facility have attracted partners from across the globe.

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,600+ scientific posters on ePosters
  • More than 3,800+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Corgenix Announces Partnership with Health Diagnostic Laboratory
Corgenix Medical Corporation has announced a strategic partnership with Health Diagnostic Laboratory, Inc. for the development of a clinical Laboratory Developed Test.
Thursday, October 31, 2013
Corgenix Announces Diagnostic Development Agreement with Lilly
Companies to focus on potential companion diagnostic opportunity.
Thursday, May 23, 2013
Corgenix Announces Initial Phase Completion of Clinical Trial of Rapid Test for Lassa Fever
First-to-market, point-of-care rapid diagnostic test based on recombinant antigen technology for the detection of Lassa viral hemorrhagic fever filed for CE Marking.
Tuesday, April 23, 2013
Scientific News
Will Brain Palpation Soon Be Possible?
Researchers have developed non-invasive brain imaging technique which provides the same information as physical palpation.
Groundbreaking Computer Program Diagnoses Cancer in Two Days
Researchers have combined genetics with computer science and created a new diagnostic technology can with 85 per cent certainty identify the source of the disease and thus target treatment and, ultimately, improve the prognosis for the patient.
Detecting HIV Diagnostic Antibodies with DNA Nanomachines
New research may revolutionize the slow, cumbersome and expensive process of detecting the antibodies that can help with the diagnosis of infectious and auto-immune diseases such as rheumatoid arthritis and HIV.
Horse Illness Shares Signs of Human Disease
Horses with a rare nerve condition have similar signs of disease as people with conditions such as Alzheimer’s, a study has found.
Compound Doubles Up On Cancer Detection
Researchers have found that tagging a pair of markers found almost exclusively on a common brain cancer yields a cancer signal that is both more obvious and more specific to cancer.
The Age of Humans Controlling Microbes
Engineered bacteria could soon be used to detect environmental toxins, treat diseases, and sustainably produce chemicals and fuels.
Predictive Model for Breast Cancer Progression
Biomedical engineers have demonstrated a proof-of-principle technique that could give women and their oncologists more personalized information to help them choose options for treating breast cancer.
Are Changes to Current Colorectal Cancer Screening Guidelines Required?
Editorial suggests more research is needed to pinpoint age to end aggressive screening.
New Molecular Marker for Killer Cells
Cell marker enables prognosis about the course of infections.
Sniffing Out Cancer
Scientists have been exploring new ways to “smell” signs of cancer by analyzing what’s in patients’ breath.
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,600+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,800+ scientific videos